Increased TAM density in tumors, especially CD204+ M2-like TAMs (25), correlates with poor patient prognosis in multiple cancer types, including lung cancer, while HLA-DR+ M1-like TAMs correlate with better prognosis for patients (26). This evidence concerns the gene MSR1 and cancer.